FDA Approved: FOSCARNET SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original application for Foscarnet Sodium, a generic antiviral intended for CMV and acyclovir-resistant HSV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acyclovir-resistant Mucocutaneous Herpes Simplex Virus Infections
• Cytomegalovirus Infections
• Cytomegalovirus Retinitis
• Herpes Simplex Virus Infections

Drugs mentioned

• FOSCARNET SODIUM (Foscarnet sodium)

Snippet

ORIG AP for FOSCARNET SODIUM (FOSCARNET SODIUM)